A 55-year-old man with newly diagnosed type 2 diabetes has an A1C of 8.2%, eGFR of 55 mL/min, and established cardiovascular disease. Which medication has the greatest cardiovascular mortality benefit?
-
A
Empagliflozin (SGLT-2 inhibitor)
-
B
Glipizide (sulfonylurea)
-
C
Sitagliptin (DPP-4 inhibitor)
-
D
Pioglitazone (thiazolidinedione)